Interventional Pulmonology Market

Industry Outlook

The interventional pulmonology market is expected to grow from US$ 1,145.6 million in 2017 to US$ 1,747.0 million by 2026, with a compounded annual growth rate (CAGR) of 4.8% between 2018 and 2026. As per the statistics provided by the World Health Organization (WHO), in 2018, approximately 2.09 million people died due to lung cancer. Tobacco smoking is the leading cause of the formation of malignant tumors and neoplasms in the lungs. Interventional pulmonology is a relatively new field that has gained tremendous attraction in the last decade and employs sophisticated tools to perform the diagnosis and treatment of various pulmonary disorders. Apart from pulmonologists, cardiothoracic surgeons also routinely perform interventional pulmonology procedures.

Accurate diagnosis, precise sample collection, and the increasing number of lung complications drive the flexible bronchoscopy market’s growth.

Flexible bronchoscopy is dominating the procedure-type segment of the interventional pulmonology market. Flexible bronchoscopy is useful in diagnosing different stages of lung cancer and in palliative care by debulking endobronchial lesions and treating airway stenosis. Its inherent features, such as accurate diagnosis, precise sample collection, and a significant rise in lung complications, together drive the flexible bronchoscopy market’s growth.

Pleuroscopy is gaining huge demand as an alternative to video-assisted thoracoscopic surgery (VATS), which is employed for the diagnosis of pleural effusions of unknown etiology. It is a minimally invasive surgical procedure and has successfully achieved 100% accuracy in the diagnosis of tuberculous effusion. It is a relatively well-tolerated procedure with negligible complications.

Rising lung cancer prevalence and increased health awareness drive market growth in North America.

In the current scenario, North America is dominating the regional segment of the interventional pulmonology market. The factors responsible for its market share of 35% are the rising prevalence of lung cancer and growing health awareness. According to the American Lung Association (ALA), in 2018, 234,030 new cases of lung cancer were diagnosed in the United States, which represents 13% of all diagnosed cancers. Europe holds 30% of the market share owing to the significant rise in air pollution and tobacco smoking.

Stringent norms related to early diagnosis and medical intervention drive the interventional pulmonology market’s growth in the European region. Asia Pacific represents 15% of the market on account of the increasing establishment of subsidiaries and retail outlets by major players such as Boston Scientific Corporation, Karl Storz, Medtronic Plc., Terumo Corporation, etc. Regional healthcare bodies’ supportive regulatory environments bolster market growth in the Asia Pacific region.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market is segmented by procedure and by geography.

Medical device companies competing in the interventional pulmonology market are Boston Scientific Corporation, BTG, Plc., Ethicon, Inc., ENDO-FLEX GmbH, HealthTronics, Inc., Karl Storz, Medtronic, Plc., Pulmonx, Inc., Terumo Corporation, and Varian Medical Systems, Inc.

Key questions are answered in this report.

• What are the organic and inorganic market growth strategies associated with the interventional pulmonology market?
• Which medical device manufacturers are associated with the interventional pulmonology market?
• What is the disease etiology associated with different kinds of pulmonary disorders?
• What is pleuroscopy, and how will it perform during the forecast period from 2018 to 2026?
• What is the prevalence rate of lung cancer in the Asia Pacific region, and how will it respond to existing market trends in the interventional pulmonology market?

Chapter 1. Preface
1.1. Report Scope and Descrtion
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Procedure
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global IP Market Portraiture
2.2. Global IP Market, by Procedure, 2017 (US$ Mn)
2.3. Global IP Market, by Geography, 2017 (US$ Mn)

Chapter 3. Interventional Pulmonology (IP) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global IP Market, by Key Players, 2017

Chapter 4. Global Interventional Pulmonology (IP) Market, by Procedure
4.1. Overview
4.2. Flexible Bronchoscopy
4.3. Rigid Bronchoscopy
4.4. Bronchoalveolar Lavage
4.5. Lung Biopsy
4.6. Bronchial Stent
4.7. Balloon Bronchoplasty
4.8. Pleuroscopy
4.9. Others

Chapter 5. Global Interventional Pulmonology (IP) Market, by Geography
5.1. Overview
5.2. North America IP Market Analysis, 2016 – 2026
5.2.1. North America IP Market, by Procedure, 2016 – 2026 (US$ Mn)
5.2.2. North America IP Market, by Country, 2016 – 2026 (US$ Mn)
5.2.2.1. U.S.
5.2.2.2. Canada
5.3. Europe IP Market Analysis, 2016 – 2026
5.3.1. Europe IP Market, by Procedure, 2016 – 2026 (US$ Mn)
5.3.2. Europe IP Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.3.2.1. U.K.
5.3.2.2. Germany
5.3.2.3. Rest of Europe
5.4. Asia Pacific IP Market Analysis, 2016 – 2026
5.4.1. Asia Pacific IP Market, by Procedure, 2016 – 2026 (US$ Mn)
5.4.2. Asia Pacific IP Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.4.2.1. China
5.4.2.2. Japan
5.4.2.3. Rest of Asia Pacific
5.5. Latin America IP Market Analysis, 2016 – 2026
5.5.1. Latin America IP Market, by Procedure, 2016 – 2026 (US$ Mn)
5.5.2. Latin America IP Market, by Country/Region, 2016 – 2026 (US$ Mn)
5.5.2.1. Brazil
5.5.2.2. Mexico
5.5.2.3. Rest of Latin America
5.6. Middle East & Africa IP Market Analysis, 2016 – 2026
5.6.1. MEA IP Market, by Procedure, 2016 – 2026 (US$ Mn)
5.6.2. MEA IP Market, by Region, 2016 – 2026 (US$ Mn)
5.6.2.1. GCC
5.6.2.2. Rest of MEA

Chapter 6. Company Profiles
6.1. Boston Scientific Corporation
6.1.1. Business Descrtion
6.1.2. Financial Information (Subject to data availability)
6.1.3. Product Portfolio
6.1.4. News Coverage
6.2. BTG, plc.
6.3. Ethicon, Inc.
6.4. ENDO-FLEX GmbH.
6.5. HealthTronics, Inc.
6.6. Karl Storz
6.7. Medtronic, plc.
6.8. Pulmonx, Inc.
6.9. Terumo Corporation
6.10. Varian Medical Systems, Inc.

List of Figures

FIG. 1 Interventional Pulmonology (IP) Market: Research Methodology
FIG. 2 IP: Market Segmentation
FIG. 3 Global IP Market, by Procedure, 2017 (US$ Mn)
FIG. 4 Global IP Market, by Geography, 2017 (US$ Mn)
FIG. 5 Attractive Investment Proposition: by Geography, 2017
FIG. 6 Competitive Analysis: Global IP Market, by Key Players, 2017
FIG. 7 Global Flexible Bronchoscopy Market for IP, 2016 – 2026 (US$ Mn)
FIG. 8 Global Rigid Bronchoscopy Market for IP, 2016 – 2026 (US$ Mn)
FIG. 9 Global Bronchoalveolar Lavage Market for IP, 2016 – 2026 (US$ Mn)
FIG. 10 Global Lung Biopsy Market for IP, 2016 – 2026 (US$ Mn)
FIG. 11 Global Bronchial Stent Market for IP, 2016 – 2026 (US$ Mn)
FIG. 12 Global Balloon Bronchoplasty Market for IP, 2016 – 2026 (US$ Mn)
FIG. 13 Global Pleuroscopy Market for IP, 2016 – 2026 (US$ Mn)
FIG. 14 Global Other Procedures Market for IP, 2016 – 2026 (US$ Mn)
FIG. 15 U.S. IP Market, 2016 – 2026 (US$ Mn)
FIG. 16 Canada IP Market, 2016 – 2026 (US$ Mn)
FIG. 17 U.K. IP Market, 2016 – 2026 (US$ Mn)
FIG. 18 Germany IP Market, 2016 – 2026 (US$ Mn)
FIG. 19 Rest of Europe IP Market, 2016 – 2026 (US$ Mn)
FIG. 20 China IP Market, 2016 – 2026 (US$ Mn)
FIG. 21 Japan IP Market, 2016 – 2026 (US$ Mn)
FIG. 22 Rest of Asia Pacific IP Market, 2016 – 2026 (US$ Mn)
FIG. 23 Brazil IP Market, 2016 – 2026 (US$ Mn)
FIG. 24 Mexico IP Market, 2016 – 2026 (US$ Mn)
FIG. 25 Rest of Latin America IP Market, 2016 – 2026 (US$ Mn)
FIG. 26 GCC IP Market, 2016 – 2026 (US$ Mn)
FIG. 27 Rest of Middle East and Africa IP Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 Global Interventional Pulmonology (IP) Market Portraiture
TABLE 2 Global IP Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 3 Global IP Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 4 North America IP Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 5 North America IP Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 6 Europe IP Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 7 Europe IP Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 8 Asia Pacific IP Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 9 Asia Pacific IP Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 10 Latin America IP Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 11 Latin America IP Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 12 Middle East and Africa IP Market, by Procedure, 2016 – 2026 (US$ Mn)
TABLE 13 Middle East and Africa IP Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 14 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 15 BTG, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 16 Ethicon, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 17 ENDO-FLEX GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 18 HealthTronics, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 19 Karl Storz: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 20 Medtronic, Plc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 Pulmonx, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 Terumo Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 Varian Medical Systems, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)